S.Res. 510 · 118th Congress

A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

Stage
In committee
Introduced
2023-12-14
Latest action
2023-12-14 · Introduced in Senate

Action history

  1. 2023-12-14Introduced in Senate
  2. 2023-12-14Referred to the Committee on Health, Education, Labor, and Pensions.